What is he best known for?
The fields of study Stefan Faderl is best known for:
- Chemotherapy
- Cancer
- Leukemia
Much of his study explores Internal medicine relationship to Adverse effect.
Borrowing concepts from Oncology, he weaves in ideas under Gastroenterology.
Stefan Faderl undertakes multidisciplinary studies into Oncology and Gastroenterology in his work.
While working in this field, he studies both Leukemia and Minimal residual disease.
His study deals with a combination of Minimal residual disease and Leukemia.
His Myeloid leukemia study frequently links to other fields, such as Immunology.
In most of his Immunology studies, his work intersects topics such as Myeloid leukemia.
He performs multidisciplinary studies into Gene and Genetics in his work.
He integrates Genetics and Gene in his research.
His most cited work include:
- Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia (903 citations)
- Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies (736 citations)
- Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia (623 citations)
What are the main themes of his work throughout his whole career to date
His study in Biochemistry and Genetics is carried out as part of his Gene studies.
His Biochemistry study frequently links to related topics such as Gene expression.
He performs multidisciplinary study on Gene expression and DNA methylation in his works.
Stefan Faderl incorporates Genetics and Gene in his research.
Internal medicine and Adverse effect are commonly linked in his work.
Stefan Faderl conducted interdisciplinary study in his works that combined Gastroenterology and Oncology.
He conducted interdisciplinary study in his works that combined Oncology and Gastroenterology.
He merges Leukemia with Chronic lymphocytic leukemia in his study.
His research combines Cytarabine and Myeloid leukemia.
Stefan Faderl most often published in these fields:
- Internal medicine (94.62%)
- Gastroenterology (66.86%)
- Leukemia (61.19%)
What were the highlights of his more recent work (between 2013-2020)?
- Internal medicine (93.94%)
- Gastroenterology (63.64%)
- Leukemia (57.58%)
In recent works Stefan Faderl was focusing on the following fields of study:
The study of Internal medicine is intertwined with the study of Toxicity in a number of ways.
His work in Toxicity is not limited to one particular discipline; it also encompasses Internal medicine.
He performs multidisciplinary study in Gastroenterology and Oncology in his work.
By researching both Oncology and Gastroenterology, Stefan Faderl produces research that crosses academic boundaries.
In his research, he undertakes multidisciplinary study on Leukemia and Neutropenia.
In his articles, Stefan Faderl combines various disciplines, including Neutropenia and Leukemia.
Myeloid leukemia is closely attributed to Imatinib in his research.
Imatinib and Dasatinib are two areas of study in which he engages in interdisciplinary research.
Many of his studies involve connections with topics such as Myeloid leukemia and Dasatinib.
Between 2013 and 2020, his most popular works were:
- Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab (179 citations)
- Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (160 citations)
- Declining rates of treatment-related mortality in patients with newly diagnosed AML given ‘intense’ induction regimens: a report from SWOG and MD Anderson (137 citations)
In his most recent research, the most cited works focused on:
- Chemotherapy
- Leukemia
- Gene
Many of his studies on Internal medicine apply to Multivariate analysis as well.
His Prednisone research extends to the thematically linked field of Gastroenterology.
Prednisone is often connected to Gastroenterology in his work.
In his articles, Stefan Faderl combines various disciplines, including Leukemia and Neutropenia.
In his works, he undertakes multidisciplinary study on Neutropenia and Leukemia.
Myeloid leukemia and White blood cell are two areas of study in which Stefan Faderl engages in interdisciplinary research.
He merges White blood cell with Myeloid leukemia in his study.
Many of his studies involve connections with topics such as Induction therapy and Chemotherapy.
His Chemotherapy research extends to Induction therapy, which is thematically connected.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
